Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
52 pending office actions • 36 clients • 49 examiners • 31 art units • 0 of 52 (0%) have an AI response strategy ready
KAGAN BINDER, PLLC focuses on Biotechnology & Pharmaceuticals. It has 2672 career applications. The firm has a resolved allowance rate of 81.43 percent. It averages 3.78 office actions per allowance. There are 39 pending office actions.
The 81.43 percent allowance rate is based on 2672 career applications. The average of 3.78 office actions per allowance provides a measure of prosecution efficiency. The 39 pending office actions represent the firm's current active cases in the biotechnology sector.
Based on the USPTO statutory response window for each pending office action. 16 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 16 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (2%) |
| §101 + other | 5 (10%) |
| §103 only | 12 (23%) |
| §102 only | 2 (4%) |
| §112 only | 5 (10%) |
| Double-patenting only | 1 (2%) |
| Double-patenting + other | 3 (6%) |
| Multi-statute (no §101) | 23 (44%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOLLAND, PAUL J | 2 | 57.5% | +64.6% |
| HENSON, KATINA N | 2 | 56.6% | +31.9% |
| QIAN, CELINE X | 2 | 47.6% | +16.9% |
| HUTCHINSON, ALAN D | 1 | 78.8% | +16.9% |
| GANCI, MATTHEW JOSEPH | 1 | 93.1% | -2.9% |
| HERNANDEZ, JACKSON J | 1 | 51.4% | +45.0% |
| WHALEY, PABLO S | 1 | 25.1% | +21.4% |
| GARBER, ERIN R | 1 | 82.7% | +17.7% |
| MILIA, MARK R | 1 | 58.9% | +22.2% |
| PACKARD, BENJAMIN J | 1 | 66.7% | +15.6% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19141640 | HYDRAULIC ACTUATOR FOR A SPRING PRELOAD ADJUSTMENT SYSTEM FOR A SHOCK ABSORBER | GANCI, MATTHEW JOSEPH | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17413468 | BARN DUST EXTRACT FOR THE PREVENTION AND TREATMENT OF DISEASES | BENAVIDES, JENNIFER ANN | 113d overdue |
| 18572315 | Crumble feed formulation for ruminant animals and method for preparing said crumble feed formulation | MCNEIL, JENNIFER C | 87d overdue |
| 18033524 | IL-2/IL-15R-BETA-GAMMA AGONIST FOR TREATING NON-MELANOMA SKIN CANCER | ABBAS, SYED JARAR | 73d overdue |
| 18277041 | PATIENT SELECTION FOR TREATMENT WITH DENDRITIC CELL VACCINATION | JUEDES, AMY E | 30d overdue |
| 18206206 | SAMPLING CATHETER | KREMER, MATTHEW | 28d overdue |
| 18286844 | DAMPING CARTRIDGE SYSTEM FOR VEHICLE FRONT FORKS | TORRES WILLIAMS, MELANIE | 9d overdue |
| 18702276 | PROCESS FOR COATING A GRANULAR MATERIAL, COATED GRANULAR MATERIAL AND KIT | WALTERS JR, ROBERT S | 3d overdue |
| 18020915 | AMINO-MODIFIED CHIP, PREPARATION METHOD THEREFOR AND USE THEREOF | CROW, ROBERT THOMAS | 29d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18880793 | SURFACE TREATMENT METHOD, SEQUENCING METHOD, AND KIT | HERNANDEZ, JACKSON J | 30d overdue |
| 17252565 | Dissolvable Wet Wipe | HENSON, KATINA N | 54d |
| 19289333 | METHOD FOR CONTROLLING A BICYCLE CONFIGURATION | HUTCHINSON, ALAN D | — |
| 18999061 | METHOD AND APPARATUS FOR DETECTING CHROMOSOMAL ANEUPLOIDY, DEVICE AND STORAGE MEDIUM | WHALEY, PABLO S | — |
| 18961674 | OPTOMECHANICAL SYSTEM AND SEQUENCING SYSTEM | GARBER, ERIN R | — |
| 18950631 | METHOD AND APPARATUS FOR DETERMINING INTER-CHANNEL CROSSTALK CORRECTION STRENGTH, AND MEDIUM | MILIA, MARK R | — |
| 18937498 | N-CONTAINING/HUMIC FERTILIZER AND PREPARING METHODS THEREOF | PACKARD, BENJAMIN J | — |
| 18329503 | MEANS AND METHODS FOR MODIFYING MULTIPLE ALLELES | HOLLAND, PAUL J | — |
| Art Unit | Apps |
|---|---|
| 3723 | 3 |
| 1652 | 3 |
| 1656 | 3 |
| 3791 | 2 |
| 1675 | 2 |
| 1637 | 2 |
| 3614 | 1 |
| 1627 | 1 |
| 3619 | 1 |
| 2878 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19289333 | METHOD FOR CONTROLLING A BICYCLE CONFIGURATION | Ohlins Group AB | HUTCHINSON, ALAN D | DP | Non-Final OA | — | Pending | Aug 04, 2025 | |
| 19141640 | HYDRAULIC ACTUATOR FOR A SPRING PRELOAD ADJUSTMENT SYSTEM FOR A SHOCK ABSORBER | Öhlins Group AB | GANCI, MATTHEW JOSEPH | 3614 | §103 | Non-Final OA | — | Pending | Jun 20, 2025 |
| 18880793 | SURFACE TREATMENT METHOD, SEQUENCING METHOD, AND KIT | Genemind Biosciences Co., Ltd. | HERNANDEZ, JACKSON J | 1627 | §112 | Final Rejection | 30d overdue | Pending | Jan 02, 2025 |
| 18999061 | METHOD AND APPARATUS FOR DETECTING CHROMOSOMAL ANEUPLOIDY, DEVICE AND STORAGE MEDIUM | Genemind Biosciences Co., Ltd. | WHALEY, PABLO S | 3619 | §101§102§112 | Non-Final OA | — | Pending | Dec 23, 2024 |
| 18961674 | OPTOMECHANICAL SYSTEM AND SEQUENCING SYSTEM | Genemind Biosciences Co., Ltd. | GARBER, ERIN R | 2878 | §103§112 | Non-Final OA | — | Pending | Nov 27, 2024 |
| 18950631 | METHOD AND APPARATUS FOR DETERMINING INTER-CHANNEL CROSSTALK CORRECTION STRENGTH, AND MEDIUM | Genemind Biosciences Co., Ltd. | MILIA, MARK R | §103 | Non-Final OA | — | Pending | Nov 18, 2024 | |
| 18937498 | N-CONTAINING/HUMIC FERTILIZER AND PREPARING METHODS THEREOF | Huma, Inc. | PACKARD, BENJAMIN J | §102§103 | Non-Final OA | — | Pending | Nov 05, 2024 | |
| 18818954 | IMAGING SYSTEM, SEQUENCING SYSTEM, AND IMAGING METHOD | Genemind Biosciences Co., Ltd. | CROCKETT, RYAN M | §102§103 | Non-Final OA | — | Pending | Aug 29, 2024 | |
| 18798368 | IMAGING SYSTEM AND SEQUENCING SYSTEM | Genemind Biosciences Co., Ltd. | MERLIN, JESSICA M | §103 | Final Rejection | — | Pending | Aug 08, 2024 | |
| 18834180 | CARBON BRUSH AND METHOD OF SUPPLYING POWER TO A CARBON BRUSH SENSOR | AB Dynamoborstfabriken | HARCUM, MARCUS E | §102 | Non-Final OA | — | Pending | Jul 29, 2024 | |
| 18725026 | RESIN COMPOSITION, AND PREPREG AND USE THEREOF | Research Institute Of Tsinghua, Pearl River Delta | COPENHEAVER, BLAINE R | 1781 | §103 | Non-Final OA | — | Pending | Jun 27, 2024 |
| 18652140 | METHOD FOR RECOVERING VALUABLE METALS FROM SPENT CATALYSTS | Kenit International, Inc. | WANG, NICHOLAS A | §102§103§112 | Non-Final OA | — | Pending | May 01, 2024 | |
| 18702276 | PROCESS FOR COATING A GRANULAR MATERIAL, COATED GRANULAR MATERIAL AND KIT | Ask Chemicals GmbH | WALTERS JR, ROBERT S | 1717 | §102§103 | Final Rejection | 3d overdue | Pending | Apr 17, 2024 |
| 18701537 | HLA GENE AMPLIFICATION PRIMER, KIT, SEQUENCING LIBRARY CONSTRUCTION METHOD, AND SEQUENCING METHOD | Xi'An Haorui Gene Technologies Ltd. | TSUI, YUNG-SHENG M | §101§102§103§112 | Non-Final OA | — | Pending | Apr 15, 2024 | |
| 18686220 | BRUSH FOR MAINTENANCE OF INDOOR AND OUTDOOR PADEL TURFS | Padmax Group AB | HORTON, ANDREW ALAN | 3723 | §103 | Final Rejection | 7d | Pending | Feb 23, 2024 |
| 18683180 | IL-2/IL-15RBETAGAMMA AGONIST COMBINATION WITH ANTIBODY-DRUG CONJUGATES FOR TREATING CANCER | Cytune Pharma | BEANE, RANDALL L | §103§112Other | Non-Final OA | — | Pending | Feb 12, 2024 | |
| 18403262 | CRUDE STEROL AS AN ADDITIVE IN ASPHALT BINDER | Ergon Asphalt & Emulsions, Inc. | MERKLING, SALLY ANNE | 1738 | §103§112DP | Non-Final OA | — | Pending | Jan 03, 2024 |
| 18573397 | INTERLEUKIN-15 BASED IMMUNOCYTOKINES | Sotio Biotech A.S. | BUTTICE, AUDREY L | §102§103§112 | Non-Final OA | — | Pending | Dec 21, 2023 | |
| 18572315 | Crumble feed formulation for ruminant animals and method for preparing said crumble feed formulation | Graincorp Limited | MCNEIL, JENNIFER C | 1793 | §102§103 | Final Rejection | 87d overdue | Pending | Dec 20, 2023 |
| 18570632 | CLASSIFICATION USING ARTIFICIAL INTELLIGENCE STRATEGIES THAT RECONSTRUCT DATA USING COMPRESSION AND DECOMPRESSION TRANSFORMATIONS | Microtrace, LLC | HASTY, NICHOLAS | §101§102§103 | Non-Final OA | — | Pending | Dec 15, 2023 | |
| 18562690 | SNUS CONTAINER | SÄVJO PLASTIC AB | REYNOLDS, STEVEN ALAN | 3735 | §103 | Final Rejection | — | Pending | Nov 20, 2023 |
| 18388057 | TOPICAL COMPOSITION CONTAINING CANNABINOIDS | Tf Holdings LLC | AGGARWAL, SAHIL CHANDER | 1623 | §103 | Final Rejection | — | Pending | Nov 08, 2023 |
| 18289283 | COMPOSITION COMPRISING AN INHIBITOR OF MITOCHONDRIAL TRANSCRIPTION | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | SAMSELL, RILLA MARIE | 1624 | §103§112DP | Non-Final OA | — | Pending | Nov 02, 2023 |
| 18287437 | A METHOD AND DEVICE FOR PRODUCING A PRODUCT COMPRISING A SUBSTRATE WITH AT LEAST ONE PATTERNED LAYER | Dp Patterning AB | ABRAHAM, JOSE K | §103§112 | Non-Final OA | — | Pending | Oct 18, 2023 | |
| 18286844 | DAMPING CARTRIDGE SYSTEM FOR VEHICLE FRONT FORKS | Öhlins Group AB | TORRES WILLIAMS, MELANIE | 3616 | §102§103 | Final Rejection | 9d overdue | Pending | Oct 13, 2023 |
| 18281489 | METHOD FOR EXTRACTING RESPIRATORY INFORMATION FROM A BIO-IMPEDANCE SIGNAL | Onera Technologies B.V. | AGAHI, PUYA | 3791 | §101 | Final Rejection | 34d | Pending | Sep 11, 2023 |
| 18280908 | VACCINE COMPOSITIONS AND METHODS FOR TREATING HSV | Redbiotec AG | GRIZER, CASSANDRA SENN | 1672 | §101§103§112DP | Non-Final OA | — | Pending | Sep 07, 2023 |
| 18242912 | MICROORGANISMS AND METHODS FOR THE PRODUCTION OF BIOSYNTHESIZED TARGET PRODUCTS HAVING REDUCED LEVELS OF BYPRODUCTS | Genomatica, Inc. | RAMIREZ, DELIA M | 1652 | §102§112 | Final Rejection | — | Pending | Sep 06, 2023 |
| 18277535 | POLYSACCHARIDE COMPLEX | Acaryon GmbH | BRANDSEN, BENJAMIN MICHAEL | 1693 | §102§103§112 | Non-Final OA | — | Pending | Aug 16, 2023 |
| 18277041 | PATIENT SELECTION FOR TREATMENT WITH DENDRITIC CELL VACCINATION | Sctbio A.S. | JUEDES, AMY E | 1644 | §101§102§112Other | Non-Final OA | 30d overdue | Pending | Aug 11, 2023 |
| 18228881 | WOUND TREATMENT TOPICAL COMPOSITION CONTAINING CANNABINOIDS | Tf Holdings LLC | WARD, PAUL V | 1622 | §102 | Non-Final OA | — | Pending | Aug 01, 2023 |
| 18270154 | EPOXY RESIN COMPOSITION AND TRANSPARENT COMPOSITE MATERIAL COMPRISING SAME, AND LAMINATED BOARD | Guangdong Hinno-Tech Co., Ltd. | HESTER, HOLLEY GRACE | 1766 | §103 | Non-Final OA | 23d | Pending | Jun 28, 2023 |
| 18268948 | APPLICATION OF CRISPR/CAS13 FOR THERAPY OF RNA VIRUS AND/OR BACTERIUM INDUCED DISEASES | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | MOAZZAMI, NAGHMEH NINA | 1652 | §103DP | Final Rejection | 9d | Pending | Jun 21, 2023 |
| 18265857 | EXOGENOUS GENE CONTROLLABLE EXPRESSION VIRUS PACKAGING VECTOR AND PACKAGING METHOD | Obio Technology (Shanghai) Corp., Ltd. | MCCORMICK, CATHERINE LYNN | 1638 | §103 | Final Rejection | — | Pending | Jun 07, 2023 |
| 18206206 | SAMPLING CATHETER | Imperial College Innovations Limited | KREMER, MATTHEW | 3791 | §103§112 | Non-Final OA | 28d overdue | Pending | Jun 06, 2023 |
| 18329503 | MEANS AND METHODS FOR MODIFYING MULTIPLE ALLELES | Octapharma AG | HOLLAND, PAUL J | 1656 | §112 | Non-Final OA | — | Pending | Jun 05, 2023 |
| 18329520 | MEANS AND METHODS FOR MODIFYING MULTIPLE ALLELES | Octapharma AG | HOLLAND, PAUL J | 1656 | §112 | Non-Final OA | — | Pending | Jun 05, 2023 |
| 18039060 | TCR CAPABLE OF RECOGNIZING HPV ANTIGEN | Xlifesc, Ltd. | PETERS, ALEC JON | 1641 | §112 | Non-Final OA | 15d | Pending | May 26, 2023 |
| 18038393 | BIOCOMPATIBLE COMPOSITE MEMBRANE, METHOD FOR FABRICATING THE MEMBRANE, BIOREACTOR AND METHOD FOR INVESTIGATING CELLS ATTACHED TO THE BIOCOMPATIBLE COMPOSITE MEMBRANE | Julius-Maximilians-Universitaet Wuerzburg | PAGUIO FRISING, MICHELLE F | 1651 | §102§103§112 | Non-Final OA | — | Pending | May 23, 2023 |
| 18033773 | IL-2/IL-15R-BETA-GAMMA AGONIST FOR TREATING SQUAMOUS CELL CARCINOMA | Cytune Pharma | CESARE, JOSEPH DAVID | 1675 | §103 | Final Rejection | — | Pending | Apr 25, 2023 |
| 18033524 | IL-2/IL-15R-BETA-GAMMA AGONIST FOR TREATING NON-MELANOMA SKIN CANCER | Cytune Pharma | ABBAS, SYED JARAR | 1674 | §102§112Other | Non-Final OA | 73d overdue | Pending | Apr 24, 2023 |
| 18020915 | AMINO-MODIFIED CHIP, PREPARATION METHOD THEREFOR AND USE THEREOF | Genemind Biosciences Co., Ltd. | CROW, ROBERT THOMAS | 1682 | §103§112 | Non-Final OA | 29d | Pending | Feb 10, 2023 |
| 18083154 | DISSOLVABLE WET WIPE | Mccormack Innovation Limited | HENSON, KATINA N | 3723 | §103§112 | Final Rejection | — | Pending | Dec 16, 2022 |
| 18010407 | CELL-MEDIATED SARS-COV-2 VACCINES, AND PREPARATION AND USE THEREOF | Xiushan Yin | QIAN, CELINE X | 1637 | §103 | Final Rejection | — | Pending | Dec 14, 2022 |
| 17920606 | COMPOSITION COMPRISING A DNA-DEGRADING ENZYME FOR USE IN A METHOD FOR THE TREATMENT OF IMMUNOSUPPRESSION AFTER ACUTE TISSUE INJURY | Klinikum Der Universität München | SWIFT, CANDICE LEE | 1657 | §102§112 | Final Rejection | — | Pending | Oct 21, 2022 |
| 17843589 | NON-NATURAL MICROBIAL ORGANISMS WITH IMPROVED ENERGETIC EFFICIENCY | Genomatica, Inc. | ROBINSON, HOPE A | 1652 | §112 | Final Rejection | 31d overdue | Pending | Jun 17, 2022 |
| 17780421 | ENGINEERED CELLS FOR PRODUCTION OF CANNABINOIDS AND OTHER MALONYL-CoA-DERIVED PRODUCTS | Genomatica, Inc. | QIAN, CELINE X | 1637 | §103§112 | Non-Final OA | — | Pending | May 26, 2022 |
| 17776564 | COMBINATION PRODUCT FOR DNA DETECTION | Guangzhou Pluslife Biotech Co., Ltd. | KIM, YOUNG J | 1681 | §103§112 | Final Rejection | — | Pending | May 12, 2022 |
| 17634117 | WEARABLE SENSOR DEVICE | Onera Technologies B.V. | ROBINSON, NICHOLAS A | 3798 | §103§112 | Non-Final OA | — | Pending | Feb 09, 2022 |
| 17605499 | ENGINEERED TRANSAMINASE AND METHODS OF MAKING AND USING | Genomatica, Inc. | MCKNIGHT, CIARA A | 1656 | §103§112 | Non-Final OA | — | Pending | Oct 21, 2021 |
| 17413468 | BARN DUST EXTRACT FOR THE PREVENTION AND TREATMENT OF DISEASES | The Arizona Board Of Regents On Behalf Of The University Of Arizona | BENAVIDES, JENNIFER ANN | 1675 | §103§112 | Non-Final OA | 113d overdue | Pending | Jun 11, 2021 |
| 17252565 | Dissolvable Wet Wipe | Mccormack Innovation Limited | HENSON, KATINA N | 3723 | §103 | Non-Final OA | 54d | Pending | Dec 15, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial